Cisplatin induces cytoplasmic to nuclear translocation of nucleotide excision repair factors among spiral ganglion neurons

Hearing Research

Volumn 239, Issue 1-2, 2008, Pages 79-91

  Guthrie, O'neil W ^a,b,d   Li Korotky, Ha Sheng ^a,b   Durrant, John D ^a,b   Balaban, Carey ^a,b,c  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b University of Pittsburgh School of Medicine   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cisplatin; DNA adduct; Nucleotide excision repair; Ototoxicity; Spiral ganglion neurons; Xeroderma pigmentosum

Indexed keywords

CISPLATIN; MESSENGER RNA; RNA POLYMERASE II; XERODERMA PIGMENTOSUM GROUP A PROTEIN; XERODERMA PIGMENTOSUM GROUP C PROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL FUNCTION; CELL SURVIVAL; COCHLEA; CONTROLLED STUDY; CYTOPLASM; DNA ADDUCT; DNA DAMAGE; DNA REPAIR; EXCISION REPAIR; FEMALE; IMMUNOHISTOCHEMISTRY; NERVE CELL LESION; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; NUCLEOTIDE SEQUENCE; OTOTOXICITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPIRAL GANGLION; SURVIVAL TIME;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; CELL NUCLEUS; CISPLATIN; CROSS-LINKING REAGENTS; CYTOPLASM; DNA ADDUCTS; DNA REPAIR; FEMALE; MODELS, BIOLOGICAL; NEURONS; RATS; RATS, INBRED F344; SPIRAL GANGLION; XERODERMA PIGMENTOSUM;

EID: 43049097827     PISSN: 03785955     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.heares.2008.01.013     Document Type: Article

References (53)

1. Boonstra A., van Oudenaren A., Baert M., van Steeg H., Leenen P.J.M., van der Horst G.T.J., Hoeijmakers J.H.J., Savelkoul H.F.J., and Garssen J. Differential ultraviolet-B-induced immunomodulation in XPA, XPC, and CSD DNA repair-deficient mice. J. Invest. Dermatol. 117 (2001) 141-146
2. Brooks P.J., Wise D.S., Berry D.A., Kosmoski J.V., Smerdon M.J., Somers R.L., Mackie H., Spoonde A.Y., Ackerman E.J., Coleman K., Tarone R.E., and Robbins J.H. The oxidative DNA lesion 8,5′-(S)-cyclo-2′-deoxyadenosine is repaired by the nucleotide excision repair pathway and blocks gene expression in mammalian cells. J. Biol Chem. 275 (2000) 22355-22362
3. Cheng P.-W., Kaga K., Koyama S., and Kondo K. Temporal bone histopathology after treatment by a large amount of cisplatin: a case study. Otolaryngol. Head Neck Surg. 125 (2001) 411-413
4. Chen Z., Xu X.S., Yang J., and Wang G. Defining the function of XPC protein in psoralen and cisplatin-mediated DNA repair and mutagenesis. Carcinogenesis 24 (2003) 1111-1121
5. Clerici W.J., Hensley K., DiMartino D.L., and Butterfield D.A. Direct detection of ototoxicant-induced reactive oxygen species generation in cochlear explants. Hear. Res. 8 (1996) 116-124
6. Costa R.M.A., Chigancas V., Galhardo R.D.S., Carvalho H., and Menck C.F.M. The eukaryotic nucleotide excision repair pathway. Biochimie 85 (2003) 1083-1099
7. Dabholkar M., Vionnet J., Bostick-Bruton F., Yu J.J., and Reed E. Messenger RNA levels of XPAC and ERCC1 in ovarian cancer tissue correlate with response to platinum-based chemotherapy. J. Clin. Invest. 94 (1994) 703-708
8. de Laat W.L., Jaspers N.G.J., and Hoeijmakers J.H.J. Molecular mechanism of nucleotide excision repair. Gene. Dev. 13 (1999) 768-785
9. D'Errico M., Parlanti E., Teson M., de Jesus B.M., Degan P., Calcagnile A., Jaruga P., Bjørås M., Crescenzi M., Pedrini A.M., Egly J.M., Zambruno G., Stefanini M., Dizdaroglu M., and Dogliotti E. New functions of XPC in the protection of skin cells from oxidative damage. EMBO J. 25 (2006) 4305-4315
10. Eastman A. Reevaluation of interaction of cis-dichloro(ethylenediamine)platinum(II) with DNA. Biochemistry 25 (1986) 3912-3915
11. Ekborn A., Laurell G., Andersson A., Wallin I., Eksborg S., and Ehrsson H. Cisplatin-induced hearing loss: Influence of mode of drug administration in the guinea pig. Hear. Res. 140 (2000) 38-44
12. Ferry K.V., Hamilton T.C., and Johnson S.W. Increased nucleotide excision repair in cisplatin resistant ovarian cancer cells. Biochem. Pharmacol. 60 (2000) 1305-1313
13. Fichtinger-Schepman A.M., van Oosterom A.T., Lohman P.H., and Berends F. cis-Diamminedichloroplatinum(II)-induced DNA adducts in peripheral leukocytes from seven cancer patients: Quantitative immunochemical detection of the adduct induction and removal after a single dose of cis-diamminedichloroplatinum(II). Cancer Res. 47 (1987) 3000-3004
14. Fraval H.N., and Roberts J.J. Excision repair of cis-diamminedichloroplatinum(II)-induced damage to DNA of Chinese hamster cells. Cancer Res. 39 (1979) 1793-1797
15. Giaccone G. Clinical perspectives on platinum resistance. Drugs 59 Suppl. 4 (2000) 9-17
16. Gillet L.C.J., and Schärer O.D. Molecular mechanisms of mammalian global excision repair. Chem. Rev. 106 (2006) 253-276
17. Goto S., Iida T., Cho S., Oka M., Kohno S., and Kondo T. Overexpression of glutathione S-transferase pi enhances the adduct formation of cisplatin with glutathione in human cancer cells. Free Radical Res. 31 (1999) 549-558
18. Hoistad D.L., Ondrey F.G., Mutlu C., Schachern P.A., Paparella M.M., and Adams G.L. Histopathology of human temporal bone after cis-platinum, radiation, or both. Otolaryngol. Head Neck Surg. 118 (1998) 825-832
19. Ishikawa T., and Ali-Osman F. Glutathione-associated cis-diamminedichloroplatinum(II) metabolism and ATP-dependent efflux from leukemia cells: molecular characterization of glutathione-platinum complex and its biological significance. J. Biol. Chem. 268 (1993) 20116-20125
20. Kartalou M., and Essigmann J.M. Recognition of cisplatin adducts by cellular proteins. Mutat. Res. 478 (2001) 1-21
21. Kelland L.R. Preclinical perspectives on platinum resistance. Drugs 59 Suppl. 4 (2000) 1-8
22. Koberle B., Masters J.R.W., Hartkey J.A., and Wood R.D. Defective repair of cisplatin-induced DNA damage caused by reduced XPA protein in testicular germ cell tumours. Curr. Biol. 9 (1999) 273-276
23. Kuraoka I., Bender C., Romieu A., Cadet J., Wood R.D., and Lindahl T. Removal of oxygen free-radical-induced 5′,8-purine cyclodeoxynucleosides from DNA by the nucleotide excision-repair pathway in human cells. Proc. Natl. Acad. Sci. USA 97 (2000) 3832-3837
24. Lainé J.-P., and Egly J.-M. When transcription and repair meet: a complex system. Trends Genet. 22 (2006) 430-436
25. Lautermann J., Crann S.A., McLaren J., and Schacht J. Glutathione-dependent antioxidant systems in mammalian inner ear: effects of aging, ototoxicity drugs and noise. Hear. Res. 114 (1997) 75-82
26. 2. Science 218 (1982) 1075-1082
27. -ΔΔCT method. Methods. 25 (2001) 402-408
28. McLean I.W., and Nakane P.K. Periodate-lysine-paraformaldehyde fixative for immunoelectron microscopy. J. Histochem. Cytochem. 22 (1974) 1077-1083
29. Minami S.B., Sha S.-H., and Schacht J. Antioxidant protection in a new animal model of cisplatin-induced ototoxicity. Hear. Res. 198 (2004) 137-143
30. Moné M.J., Bernas T., Dinant C., Goedvree F.A., Manders E.M.M., Volker M., Houtsmuller A.B., Hoeijmakers J.H.J., Vermeulen W., and van Driel R. In vivo dynamics of chromatin-associated complex formation in mammalian nucleotide excision repair. PNAS 101 (2004) 15933-15937
31. Pera M.F., Rawlings C.J., and Roberts J.J. The role of DNA repair in the recovery of human cells from cisplatin toxicity. Chem. Biol. Interact. 37 (1981) 245-261
32. Politi A., Moné M.J., Houtsmuller A.B., Hoogstraten D., Vermeulen W., Heinrich R., and van Driel R. Mathematical modeling of nucleotide excision repair reveals efficiency of sequential assembly strategies. Mol. Cell 19 (2005) 679-690
33. Rademakers S., Volker M., Hoogstraten D., Nigg A.L., Moné M.J., van Zeeland A.A., Hoeijmakers J.H.J., Houtsmuller A.B.D., and Vermeulen W. Xeroderma pigmentosum group A protein loads as a separate factor onto DNA lesions. Mol. Cellular Biol. 23 (2003) 5755-5767
34. Ravi R., Somani S.M., and Rybak L.P. Mechanism of cisplatin ototoxicity: antioxidant system. Pharmacol. Toxicol. 76 (1995) 386-396
35. Reed E., Ozols R.F., Tarone R., Yuspa S.H., and Poirier M.C. Platinum-DNA adducts in leukocyte DNA correlate with disease response in ovarian cancer patients receiving platinum-based chemotherapy. Proc. Natl. Acad. Sci. USA 84 (1987) 5024-5028
36. + solutions. Nucleic Acids Res. 31 (2003) 1605-1613
37. Riedl T., Hanaoka F., and Egly J.-M. The coming and goings of nucleotide excision repair factors on damaged DNA. EMBO J. 22 (2003) 5293-5303
38. Rosenberg E., Taher M.M., Kuemmerle N.B., Farnsworth J., and Valerie K. A truncated human xeroderma pigmentosum complementation group A protein expressed from an adenovirus sensitizes human tumor cells to ultraviolet light and cisplatin. Cancer Res. 61 (2001) 764-770
39. Schmittgen T.D., Zakrajsek B.A., Mills A.G., Gorn V., Singer M.J., and Reed M.W. Quantitative reverse transcription-polymerase chain reaction to study mRNA decay: comparison of endpoint and real-time methods. Anal. Biochem. 285 (2000) 194-204
40. Selvakumaran M., Pisarcik D.A., Bao R., Yeung A.T., and Hamilton T.C. Enhanced cisplatin cytotoxicity by disturbing the nucleotide excision repair pathway in ovarian cancer cell lines. Cancer Res. 63 (2003) 1311-1316
41. Siddik Z.H. Cisplatin: mode of cytotoxic action and molecular basis of resistance. Oncogene 22 (2003) 7265-7279
42. Slupphaug G., Kavli B., and Krokan H.E. The interacting pathways for prevention and repair of oxidative DNA damage. Mutat. Res. 531 (2003) 231-251
43. Strauss M., Towfighi J., Lord S., Lipton A., Harvey H.A., and Brown B. Cis-platin ototoxicity: clinical experience and temporal bone histopathology. Laryngoscope 93 (1983) 1554-1559
44. Szymkowski D.E., Yarema K., Essigmann J.M., Lippard S.J., and Wood R.D. An intrastrand d(GpG) platinum crosslink in duplex M13 DNA is refractory to repair by human cell extracts. Proc. Natl. Acad. Sci. USA 89 (1992) 10772-10776
45. Thoma B.S., and Vasquez K.M. Critical DNA damage recognition functions of XPC-hHR23B and XPA-RPA in nucleotide excision repair. Mol. Carcinogen. 38 (2003) 1-13
46. Thomas J.P., Lautermann J., Liedert B., Seiler F., and Thomale J. High accumulation of platinum-DNA adducts in strial marginal cells of the cochlea is an early event in cisplatin but not carboplatin ototoxicity. Mol. Pharmacol. 70 (2006) 23-29
47. Tornaletti S., Patrick S.M., Turchi J.J., and Hanawalt P.C. Behavior of T7 RNA polymerase and mammalian RNA polymerase II at site-specific cisplatin adducts in the template DNA. J. Biol. Chem. 278 (2003) 35791-35797
48. Touliatos J.S., Neitzel L., Whitworth C., Rybak L.P., and Malafa M. Effect of cisplatin on the expression of glutathione-S-transferase in the cochlea of the rat. Eur. Arch. Otorhinolaryngol. 257 (2000) 6-9
49. van Ruijven M.W.M., de Groot J.C.M.J., Hendriksen F., and Smoorenburg G.F. Immunohistochemical detection of platinated DNA in the cochlea of cisplatin-treated guinea pigs. Hear. Res. 203 (2005) 112-121
50. Welsh C., Day R., McGurk C., Masters J.R., Wood R.D., and Koberle B. Reduced levels of XPA, ERCC1 and XPF DNA repair proteins in testis tumor cell lines. Int. J. Cancer 110 (2004) 352-361
51. Wu X., Fan W., Xu S., and Zhou Y. Sensitization to the cytotoxicity of cisplatin by transfection with nucleotide excision repair gene xeroderma pigmentosum group A antisense RNA in human lung adenocarcinoma cells. Clin. Cancer Res. 9 (2003) 5874-5879
52. Wu X., Shell S.M., Liu Y., and Zou Y. ATR-dependent checkpoint modulates XPA nuclear import in response to UV irradiation. Oncogene 26 (2007) 757-764
53. Zastawny T.H., Olejniczak W., and Olinski R. Cis-DDP induced alteration of DNA structure studied by scanning tunneling microscopy. Acta Biochim. Pol. 40 (1993) 555-558